July 2026 – September 2026

Timothy Anderson, MD, MAS (with T. W. Park, MD) // General Internal Medicine
Use and effectiveness of medications for opioid use disorder in older adults with multimorbidity
R01 DA064664
Start Date: September 1, 2026
End Date: June 30, 2031
Total Costs: $701,569

Riyue Bao, PhD (with S. Paul Monga, MD) // Malignant Hematology and Medical Oncology
Rewiring Tumor Metabolism to Overcome Immune Exclusion
R01 CA318439
Start Date: September 1, 2026
End Date: August 31, 2031
Total Costs: $657,166

Juliane Beier, PhD // Gastroenterology, Hepatology and Nutrition
The East Palestine Train Derailment Health Research Program – Continuation
OT2 ES038710 Supplement
Start Date: September 1, 2026
End Date: August 31, 2027
Total Annual Cost: $489,001

Kambez Benam, DPhil // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Next-Generation Human Lung-on-a-Chip Technologies for Rapid Evaluation of Antiviral Countermeasures in High-Containment Laboratories
Medical Technology Enterprise Consortium (MTEC)
Start Date: September 3, 2026
End Date: August 31, 2031
Total Annual Costs: $1,437,165

Yu-Chiao Chiu, PhD // Malignant Hematology and Medical Oncology
Data-driven discovery of drug response mechanisms through biologically informed deep learning and large language models
R01 LM015188
Start Date: August 4, 2026
End Date: May 31, 2030
Total Costs: $357,750

Becky Clarkson, PhD // Geriatric Medicine
Phenotyping nighttime awakenings in older adults: development of a novel system for at-home sleep and bladder monitoring
R21 AG099354
Start Date: September 15, 2026
End Date: August 31, 2028
Total Costs: $463,883

Renee Cloutier, PhD // General Internal Medicine
ARC/SAAFE Support – Fulton
Fulton County Family Partnership
Start Date: September 17, 2026
End Date: August 31, 2027
Total Costs: $49,999

Renee Cloutier, PhD // General Internal Medicine
Pennsylvania Opioid Misuse and Addiction Abatement Trust Technical Assistance and Reporting Support
Pennsylvania Opioid Misuse and Addiction Abatement Trust
Start Date: July 6, 2026
End Date: June 30, 2029
Total Costs: $1,188,862

Lee Harrison, MD // Infectious Diseases
ABC’s/Maryland Emerging Infections Program (2026-2027)
Johns Hopkins Bloomberg School of Public Health
Start Date: August 5, 2026
End Date: June 30, 2027
Total Costs: $286,760

Rimi Hazra, PhD // Classical Hematology/Vascular Medicine Institute
Heme-CRH axis as a mechanistic driver for white matter injury and cognitive impairment in sickle cell disease
American Society of Hematology Award for Research Careers in Hematology (ARCH)
Start Date: August 14, 2026
End Date: July 31, 2028
Total Annual Costs: $75,000
>> Read more about this award

Kyle Inman, MD // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Identifying the role of Complement Factor B in the host immune response and survival during acute respiratory failure
F32 HL179830
Start Date: August 1, 2026
End Date: June 30, 3027
Total Costs: $89,476

Sawa Ito, MD, PhD // Malignant Hematology and Medical Oncology
Interferon-γ in combination with donor leukocyte infusion to treat relapsed acute myeloid leukemia and myelodysplastic syndromes after haploidentical donor stem cell transplantation
R21 CA307892
Start Date: September 1, 2026
End Date: August 31, 2028
Total Costs: $408,829

Manisha Jhamb, MD, MPH // Renal-Electrolyte
Enhancing PCP-Nephrologist Co-Management for CKD: Leveraging Population Health Management and Learning Health System for Scalable Solutions
R01 DK144089
Start Date: June 24, 2026
End Date: March 31, 2030
Total Costs: $753,479

Brett Kaufman, PhD // Cardiology/VMI
Novel PNA approaches to targeting mtDNA heteroplasmy
R01 GM158880
Start Date: September 1, 2026
End Date: August 31, 2030
Total Costs: $414,677

Melanie Koenigshoff, MD, PhD, and Frank Sciurba, MD // Pulmonary, Allergy, Critical Care, and Sleep Medicine
2026 Pittsburgh International Lung Conference: The Evolving Landscape of COPD: Bridging New Mechanisms and Emerging Therapies
R13 HL188832
Start Date: August 10, 2026
End Date: July 31, 2027
Total Costs: $35,000

Danica Lee (D. Schwartz Lab) // Rheumatology and Clinical Immunology
Regulation of type I interferon signaling by A20 (TNFAIP3) in autoimmune and autoinflammatory disease
F30 AI200161
Start Date: September 1, 2026
End Date: August 31, 2029
Total Costs: $55,114

Jane Liebschutz, MD, MPH, and Erin Winstanley, PhD // General Internal Medicine
University of Pittsburgh Collaboration in Addiction Training Scholars (PittCATS) Program
K12 DA050607
Start Date: July 1, 2020*
End Date: June 30, 2031
Total Annual Costs: $809,788

Jing Luo, MD, MPH // General Internal Medicine
OFF-RAMP Feasibility: a pilot trial comparing different off-ramping strategies for maintaining weight loss among adults using incretin based therapies for obesity
R01 DK148666
Start Date: September 14, 2026
End Date: June 30, 2029
Total Annual Costs: $307,380

Jared Magnani, MD, MSc, and Kaleab Abebe, PhD // Cardiology and General Internal Medicine
The Hypertension Toolkit: an adaptive mobile health blood pressure intervention
R61 HL183037
Start Date: July 13, 2026
End Date: June 30, 2027
Total Costs: $1,019,556

Madison Martinez, MD, MPH // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Clinical Fellowship – Education and Training Award
Cystic Fibrosis Foundation
Start Date: August 14, 2026
End Date: June 30, 2028
Total Annual Costs: $75,000

Ugonna Mbaekwe (C. Kliment Lab) // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Mitochondrial Adenine Nucleotide Translocase 2 (ANT2)-Mediated Regulation of Iron, Ferroptosis, and Lung Repair in COPD
F30 HL184508
Start Date: September 9, 2026
End Date: August 31, 2030
Total Annual Costs: $55,114

Siamak Moghadam-Kia, MD, MPH // Rheumatology and Clinical Immunology
Longitudinal changes in Myositis Core Set Measures and Total Improvement Scores (TIS) in Myositis and Subtypes
RTI International 308010
Start Date: June 26, 2026
End Date: May 31, 2027
Total Costs: $250,000

John Pacella, MS, MD // Cardiology
Ultrasound-Targeted Microbubble Cavitation Therapy for Coronary Microvascular Dysfunction in Women
American Heart Association 26RWH1636923
Start Date: July 1, 2026
End Date: June 30, 2027
Total Costs: $100,000

Urvi Parikh, PhD, and Jana Jacobs, PhD (with C. Koss, MD) // Infectious Diseases
HIV-1 reservoir characterization and immune profiling of individuals with antiretroviral exposure at the time of HIV acquisition
R01 AI197903
Start Date: September 2, 2026
End Date: August 31, 2030
Total Costs: $814,507

Sanjay Patel, MD, MS // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
Brigham and Women’s Hospital GR1001231
Start Date: September 4, 2026
End Date: March 31, 2030
Total Annual Costs: $99,540

Thomas Radomski, MD, MS, and Doris Rubio, PhD // General Internal Medicine
CTSA Postdoctoral T32 at University of Pittsburgh
T32 TR006004
Start Date: August 1, 2026
End Date: June 30, 2031
Total Costs: $502,465
>> Read more about this award

Babak Razani, MD, PhD // Cardiology/VMI
Leveraging the nutrient sensing and degradative capacity of lysosomes in macrophages as a novel therapeutic approach in cardiovascular disease
R35 HL183548
Start Date: July 1, 2026
End Date: April 30, 2033
Total Annual Costs: $756,607

Charles Rinaldo, PhD; Beej Macatangay, MD; and Nic Sluis-Cremer, PhD // Infectious Diseases
University of Pittsburgh MWCCS Clinical Research Site
U01 HL146208
Start Date: April 1, 2019*
End Date: March 31, 2032
Total Annual Costs: $1,502,431

Doris Rubio, PhD, and Thomas Radomski, MD, MS // General Internal Medicine
CTSA Predoctoral T32 at University of Pittsburgh
T32 TR005991
Start Date: August 1, 2026
End Date: May 31, 2031
Total Costs: $558,631
>> Read more about this award

Doris Rubio, PhD (with K. Ray, MD) // General Internal Medicine
CTSA K12 Program at University of Pittsburgh
K12 TR005992
Start Date: August 1, 2026
End Date: May 31, 2031
Total Costs: $1,025,770
>> Read more about this award

Kienan Salvadore (L. Zhang Lab) // Pulmonary, Allergy, Critical Care, and Sleep Medicine
The Protective Role of Pulmonary Endothelial Cell Antigen Presentation in Sequential Influenza Infection
F31 HL186542
Start Date: July 6, 2026
End Date: July 5, 2029
Total Annual Costs: $50,114

Daniel Shiwarski, PhD // Vascular Medicine Institute
Advancing Fontan Patient Longevity Through Mechanistic Insights into Liver Dysfunction and Thrombosis Using 3D Bioprinted Model Systems
Additional Ventures 1587467
Start Date: August 5, 2026
End Date: June 30, 2027
Total Annual Costs: $220,000

Katie Suda, PharmD, MS // General Internal Medicine
Strengthening U.S. Pharmaceutical Supply Chains: Understanding, Predicting, and Preventing Drug Shortages (SUPPLY-US)
R01 AG103150
Start Date: September 4, 2026
End Date: June 30, 2031
Total Costs: $654,682

Katie Suda, PharmD, MS // General Internal Medicine
Drug Shortages: Improving the resiliency of the drug supply chain and access to medicines in short supply for older adults
R13 AG096987
Start Date: September 1, 2026
End Date: June 30, 2031
Total Costs: $49,999

Deepa Suryanarayan (D. Gomez Lab) // Cardiology/Vascular Medicine Institute
LINC Complex-Dependent Mechanoregulation of Smooth Muscle Cell Functions and Nuclear Organization
F31 HL186596
Start Date: August 25, 2026
End Date: March 31, 2028

Shachi Tyagi, MD, MS // Geriatric Medicine
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness (ANOWSM Study)
R21 AG095656
Start Date: July 15, 2026
End Date: June 30, 2028
Total Costs: $437,250

Daria Van Tyne, PhD // Infectious Diseases
Molecular characterization of BX004 Phase 2b results
Cystic Fibrosis Foundation
Start Date: August 1, 2026
End Date: July 31, 2027
Total Costs: $84,000

Daria Van Tyne, PhD // Infectious Diseases
Engineering of a temperate Burkholderia cepacia complex phage to improve efficacy as a potential therapeutic
J. Craig Venter Institute JCVI-26-005
Start Date: September 10, 2026
End Date: May 31, 2028
Total Annual Costs: $63,018

Flordeliza Villanueva, MD // Cardiology
Training Program in Imaging Sciences in Translational Cardiovascular Research
T32 HL129964
Start Date: July 1, 2016*
End Date: June 30, 2031
Total Annual Costs: $630,244
>> Read more about this award

Sally Wenzel, MD // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Epithelial cell fate in asthma: Ferroptotic driven mitochondrial reprogramming and vitamin E treatment
R01 AI145406
Start Date: April 20, 2020*
End Date: June 30, 2031
Total Annual Costs: $640,340

Vijay Yechoor, MD (with M. Moulik, MD) // Endocrinology and Metabolism
Clock Regulation of Stress Pathways in HFpEF
R01 HL187848
Start Date: August 17, 2026
End Date: April 30, 2030
Total Costs: $774,398

*Competitively renewed